Both Optimal Matching and Procedure Duration Influence Survival of Patients after Unrelated Donor Hematopoietic Stem Cell Transplantation

Table 1

Patients’ characteristics.

Recipient age (y), median (range)		28.5 (0.6–59)
Diagnosis, no. (%)	Hematological malignancy	73 (80)
	Immunodeficiency	9 (15)
	Aplastic anemia	4 (5)
Donor age (y), median (range)		34 (19–59)
Donor-recipient sex match, no. (%)	Female to male	23 (27)
	Other	63 (73)
Number of pregnancies in female donors, no. (%)	0-1	21 (54)
	>1	18 (46)
Donor-recipient CMV serostatus match, no. (%)	Positive-negative	10 (38)
	Negative-positive	26 (72)
Donor origin, no. (%)	Poland registry	14 (17)
	Europe foreign registry	63 (73)
	Other world registries	9 (10)
Donor-recipient HLA matching, no. (%)	Matched	50 (58)
	Mismatched	36 (42)
Number of CT procedures, no. (%)	≤2	58 (73)
	>2	22 (27)
Duration of the matching procedure (mth), median (range)		1.6 (0.27–17.8)
Hematopoietic stem cell source, no. (%)	Bone marrow	6 (7)
	Peripheral blood	80 (93)